Revista de Senologia y Patologia Mamaria最新文献_第9页

¿Cuándo hay que irradiar los ganglios después de cirugía primaria? 初次手术后何时照射神经节？

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100496

Manuel Algara , Nuria Rodríguez de Dios , Álvaro Martínez , Fan Liu , Francesco Amorelli , Javier Sanz

{"title":"¿Cuándo hay que irradiar los ganglios después de cirugía primaria?","authors":"Manuel Algara , Nuria Rodríguez de Dios , Álvaro Martínez , Fan Liu , Francesco Amorelli , Javier Sanz","doi":"10.1016/j.senol.2023.100496","DOIUrl":"10.1016/j.senol.2023.100496","url":null,"abstract":"<div><p>Radiotherapy is one of the basic mainstays of breast cancer's treatment. Nodal irradiation, including axillary, supraclavicular nodes, and internal mammary chain, is as important as the primary tumor. There is a broad consensus on the need for breast volume irradiation after conservative surgery and chest wall after mastectomy. However, regarding the nodal irradiation, there has been a continuing controversy for some years, which has increased since the abandonment of axillary lymphadenectomy in cases of low burden disease at this level. There are several studies suggesting the need or not for nodal irradiation, although many of them have the problem of not describing the received radiation dose at these levels, and so decision-making is complex. Once it has been decided that the patient is a candidate for irradiation, the second question refers to the lymph node volumes that must be treated. Finally it is necessary to determine which therapeutic scheme must be administered. In these two points, despite the existence of a higher level of evidence as well there is also controversy. This article reviews the usefulness of nodal irradiation, as well as the volumes to be irradiated and the fractionation to be used, making a therapeutic proposal.</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"36 ","pages":"Article 100496"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47968206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Arco axilar de Langer: una variante anatómica que complica la estadificación axilar del cáncer de mama 兰格腋弓：一种使乳腺癌腋窝分期复杂的解剖变异

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100550

Daniel Aparicio López, Olga Dobato Portolés, Ernesto Hernando Almudi, Carmen Casamayor Franco

引用次数: 0

Descripción de un caso de adenomatosis erosiva del pezón: tratamiento quirúrgico 一例糜烂性乳头腺瘤病的描述:手术治疗

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100526

Marcelo Chávez Díaz , Gonzalo Ziegler Rodríguez , Jaime Montes Gil

引用次数: 0

¿Se puede optimizar el tratamiento adyuvante en cáncer de mama de bajo riesgo? 是否有可能优化低风险乳腺癌的辅助治疗?

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100504

Amanda Flaquer , Andere Frias , Jon Cacicedo

{"title":"¿Se puede optimizar el tratamiento adyuvante en cáncer de mama de bajo riesgo?","authors":"Amanda Flaquer , Andere Frias , Jon Cacicedo","doi":"10.1016/j.senol.2023.100504","DOIUrl":"10.1016/j.senol.2023.100504","url":null,"abstract":"<div><p>In Oncology, we increasingly looking for the personalization of breast cancer treatment under the premise of “less is more”, there is currently a growing interest in identifying a subset of patients with early-stage breast cancer in whom the low risk of recurrence allows us to optimize adjuvant treatment. Radiotherapy in breast cancer has shown benefits at all stages and in all age groups, with minimal morbidity and excellent tolerance. Radiotherapy treatment has evolved, the volume of treatment has been reduced in low-risk subgroups (partial breast irradiation) and hypofractionated treatments, standard today, have demostrated disease control rates comparable to previous ones with a clear improvement in the quality of life of the patients. Endocrine therapy (ET) in breast cancer impacts local and distant recurrence, breast cancer-specific mortality and overall survival, but it associates significant side effects in the short, medium and long term and there are many women who have difficulty to tolerating this treatment. In this review, we try to answer questions such as: Is the omission of radiotherapy an option? And the omission of ET? In which patient profile can we consider optimizing adjuvant treatment?</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"36 ","pages":"Article 100504"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43822293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

¿Qué debe irradiarse tras tratamiento sistémico primario? 初级全身治疗后应该照射什么?

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100499

Evelyn Martínez Pérez, Silvia Comas Antón

引用次数: 0

Breast cancer and pregnancy: From an obstetrician's perspective 癌症与妊娠：从产科医生的角度

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100508

Mohsen M.A. Abdelhafez , Mohammad Saffree Jeffree , Doreen Sumpat

引用次数: 0

Farmacogenómica oncológica en el tratamiento del cáncer de mama: oportunidades y desafíos en Latinoamérica 乳腺癌治疗中的肿瘤药物基因组学：拉丁美洲的机遇和挑战

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100549

Miguel Trujillo-Martínez , Luisa María Sánchez-Zamorano , Liliana Gómez-Flores-Ramos

引用次数: 0

Prevenir el linfedema: un reto emergente 预防淋巴水肿：一个新的挑战

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100551

M. Asunción Mora Ortiz, Juan de Dios, García Contreras, Ramon Moreno Villalba, Clemente Fernández Pascual

引用次数: 0

Influence of anesthetic blockades on recurrence and spread of breast cancer 麻醉阻滞对癌症复发和扩散的影响

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100544

Maria A. Perez-Herrero , Sandra Fernandez-Caballero , Maria Fe Muñoz

{"title":"Influence of anesthetic blockades on recurrence and spread of breast cancer","authors":"Maria A. Perez-Herrero , Sandra Fernandez-Caballero , Maria Fe Muñoz","doi":"10.1016/j.senol.2023.100544","DOIUrl":"https://doi.org/10.1016/j.senol.2023.100544","url":null,"abstract":"<div><h3>Introduction</h3><p><span><span>Historically, pathological and laboratory factors are considered in the prognosis of breast cancer. Tumor resection surgery constitutes the main treatment, but paradoxically, the surgical manipulation and perioperative </span>immunosuppression may predispose to </span>cancer dissemination. Locoregional anesthetic techniques would avoid this immunosuppression, thus improving the oncologic outcomes of surgery. This study aimed to evaluate the prognostic influence of locoregional anesthesia on breast cancer dissemination and recurrence after surgery.</p></div><div><h3>Methods</h3><p><span>A retrospective cohort study was performed on 165 centrolobulillar breast cancer patients, scheduled for non-reconstructive breast oncologic surgery between 2012 and 2015. These patients were treated with conservative surgery under </span>general anesthesia (control group, n = 81) or combined anesthesia with a locoregional block (n = 84). Data were collected on age, tumor type (size, stage, lymph node infiltration), immunohistochemical factors (hormone receptors), procedure (duration, technique), anesthesia (general anesthesia or associated with regional blockade), complications, survival, and recurrence.</p></div><div><h3>Results</h3><p>Statistical analysis demonstrated no significative differences in age, weight, sex, ASA<span> status, and surgical technique and duration. Tumor recurrence was recorded in 6 patients (4 in the general group and 2 in the locoregional group) 1 year after surgery, and 6 (4 in the general group and 2 in the locoregional group) 5 years after. No significant differences between groups in morbi-mortality were found.</span></p></div><div><h3>Conclusions</h3><p>Following the interfascial analgesic technique, a lower rate of tumor recurrence was observed, but no significant differences.</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"36 4","pages":"Article 100544"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49831109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

¿Está indicada la irradiación del tumor primario en el estadio IV? iii期原发肿瘤是否需要放射治疗?

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100512

Barbara Malave , Cecilia Escuin , Miguel Árquez , Olga Engel , Fredy Castaño , Meritxell Arenas

{"title":"¿Está indicada la irradiación del tumor primario en el estadio IV?","authors":"Barbara Malave , Cecilia Escuin , Miguel Árquez , Olga Engel , Fredy Castaño , Meritxell Arenas","doi":"10.1016/j.senol.2023.100512","DOIUrl":"10.1016/j.senol.2023.100512","url":null,"abstract":"<div><p>De-novo metastatic breast cancer is a rare entity, occurring in 3–10% of cases. The most common treatment for these patients is systemic therapy (chemotherapy, hormonal therapy, targeted therapies, and combinations of these). The subgroup of patients with oligometastatic disease and low systemic disease burden may benefit more from adding a locoregional treatment. This literature review aims to analyze the benefits and disadvantages of locoregional treatment in patients with de-novo oligometastatic breast cancer. Retrospective series report that this subgroup of patients may benefit from locoregional treatment, despite presenting with metastatic disease, by improving overall survival and local control. Additionally, several retrospective series have shown that locoregional treatment with surgery, surgery and adjuvant radiotherapy, or exclusive radiotherapy present similar results in local control. Therefore, exclusive radiotherapy may be a viable alternative in these patients. In recent years, attempts have been made to demonstrate the trend of retrospective series in prospective trials. These studies have shown great heterogeneity. Some with positive results in improving overall survival and others with negative results, but not statistically significant. The main limitation of retrospective series is the selection bias, which could explain the differences in the results obtained. For this reason, locoregional treatment in these patients should be approached by multidisciplinary teams on an individualized basis, with greater consideration for oligometastatic patients.</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"36 ","pages":"Article 100512"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43033403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0